$38.42
0.05%
NYSE, Sep 17, 01:18 pm EDT. Market open.
ISIN
CH1430134226
Symbol
AMRZ
Index
SMI
Sector

Amrize Target price 2026 - Analyst rating & recommendation

Amrize Classifications & Recommendation

Buy
64%
Hold
32%
Sell
4%

Amrize Price Target

Target Price $56.10
Price $38.40
Potential 46.09%
Number of Estimates 23
23 Analysts have issued a price target Amrize 2027 . The average Amrize target price is $56.10. This is 46.09% higher than the current stock price. The highest price target is $73.50 91.41% , the lowest is $48.48 26.25% .
A rating was issued by 28 analysts: 18 Analysts recommend Amrize to buy, 9 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Amrize stock has an average upside potential 2027 of 46.09% . Most analysts recommend the Amrize stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Billion $ 11.82 12.82
0.95% 8.48%
EBITDA Margin 23.87% 25.12%
7.35% 5.25%
Net Margin 10.03% 11.13%
7.86% 10.97%

25 Analysts have issued a sales forecast Amrize 2026 . The average Amrize sales estimate is

$12.8b
unlock
. This is
5.18% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$13.3b 9.22%
unlock
, the lowest is
$12.2b 0.05%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $11.8b 0.95%
2026
$12.8b 8.48%
unlock
2027
$13.5b 5.38%
unlock
2028
$14.2b 4.98%
unlock
2029
$14.4b 1.34%
unlock
2030
$15.1b 5.03%
unlock
2031
$15.7b 4.06%
unlock
2032
$16.3b 3.97%
unlock
2033
$17.0b 3.92%
unlock

24 Analysts have issued an Amrize EBITDA forecast 2026. The average Amrize EBITDA estimate is

$3.2b
unlock
. This is
12.79% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$3.5b 21.41%
unlock
, the lowest is
$3.0b 6.27%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $2.8b 6.47%
2026
$3.2b 14.15%
unlock
2027
$3.5b 7.89%
unlock
2028
$3.8b 8.52%
unlock
2029
$4.0b 6.55%
unlock
2030
$4.2b 4.86%
unlock
2031
$4.6b 10.21%
unlock
2032
$4.8b 4.16%
unlock
2033
$5.1b 4.84%
unlock

EBITDA Margin

2025 23.87% 7.35%
2026
25.12% 5.25%
unlock
2027
25.71% 2.35%
unlock
2028
26.58% 3.38%
unlock
2029
27.95% 5.15%
unlock
2030
27.90% 0.18%
unlock
2031
29.55% 5.91%
unlock
2032
29.60% 0.17%
unlock
2033
29.87% 0.91%
unlock

24 Amrize Analysts have issued a net profit forecast 2026. The average Amrize net profit estimate is

$1.4b
unlock
. This is
18.35% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$1.6b 36.05%
unlock
, the lowest is
$1.2b 0.60%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $1.2b 6.99%
2026
$1.4b 20.35%
unlock
2027
$1.7b 15.95%
unlock
2028
$1.8b 11.17%
unlock
2029
$2.2b 17.75%
unlock
2030
$2.3b 6.48%
unlock
2031
$2.5b 7.79%
unlock
2032
$2.6b 5.19%
unlock
2033
$2.8b 6.01%
unlock

Net Margin

2025 10.03% 7.86%
2026
11.13% 10.97%
unlock
2027
12.24% 9.97%
unlock
2028
12.97% 5.96%
unlock
2029
15.06% 16.11%
unlock
2030
15.27% 1.39%
unlock
2031
15.82% 3.60%
unlock
2032
16.00% 1.14%
unlock
2033
16.33% 2.06%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share $ 2.14 2.59
6.96% 21.03%
P/E 14.80
EV/Sales 2.11

24 Analysts have issued a Amrize forecast for earnings per share. The average Amrize EPS is

$2.59
unlock
. This is
18.81% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$2.98 36.70%
unlock
, the lowest is
$2.21 1.38%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $2.14 6.96%
2026
$2.59 21.03%
unlock
2027
$3.01 16.22%
unlock
2028
$3.34 10.96%
unlock
2029
$3.94 17.96%
unlock
2030
$4.19 6.35%
unlock
2031
$4.52 7.88%
unlock
2032
$4.75 5.09%
unlock
2033
$5.04 6.11%
unlock

P/E ratio

Current
2026
14.80 15.98%
unlock
2027
12.77 13.72%
unlock
2028
11.48 10.10%
unlock
2029
9.75 15.07%
unlock
2030
9.16 6.05%
unlock
2031
8.50 7.21%
unlock
2032
8.08 4.94%
unlock
2033
7.62 5.69%
unlock

Based on analysts' sales estimates for 2026, the Amrize stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.21
2026
2.11 4.72%
unlock
2027
2.00 5.10%
unlock
2028
1.90 4.75%
unlock
2029
1.88 1.32%
unlock
2030
1.79 4.79%
unlock
2031
1.72 3.90%
unlock
2032
1.65 3.82%
unlock
2033
1.59 3.77%
unlock

P/S ratio

Current
2026
1.66 4.92%
unlock
2027
1.57 5.10%
unlock
2028
1.50 4.75%
unlock
2029
1.48 1.32%
unlock
2030
1.41 4.79%
unlock
2031
1.35 3.91%
unlock
2032
1.30 3.82%
unlock
2033
1.25 3.77%
unlock

Current Amrize Upgrades & Downgrades

Analyst Rating Action Date
Wells Fargo
Overweight
Equal-Weight
Downgrade Sep 09 2026
B of A Securities
Neutral
Underperform
Downgrade Sep 02 2026
JP Morgan
Overweight
Neutral
Downgrade Sep 02 2026
DA Davidson
Neutral
Initiated Aug 25 2026
Stephens & Co.
Overweight
Overweight
Unchanged Aug 12 2026
Citigroup
Buy
Buy
Unchanged Aug 11 2026
RBC Capital
Sector Perform
Underperform
Downgrade Aug 10 2026
Analyst Rating Date
Downgrade
Wells Fargo:
Overweight
Equal-Weight
Sep 09 2026
Downgrade
B of A Securities:
Neutral
Underperform
Sep 02 2026
Downgrade
JP Morgan:
Overweight
Neutral
Sep 02 2026
Initiated
DA Davidson:
Neutral
Aug 25 2026
Unchanged
Stephens & Co.:
Overweight
Overweight
Aug 12 2026
Unchanged
Citigroup:
Buy
Buy
Aug 11 2026
Downgrade
RBC Capital:
Sector Perform
Underperform
Aug 10 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today